Efficacy and safety of topical capsaicin in the treatment of osteoarthritis pain: A systematic review and meta‐analysis
Phytotherapy Research · 2024-07 · 38 (7) · 3695-3705
DOI: 10.1002/ptr.8223 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Phytotherapy Research, online erschienen am 18.05.2024. Verfasst von Gyem Tshering und 2 weiteren Autor:innen. Beteiligte Einrichtung: Royal Centre for Disease Control, Ministry of Health, Thimphu, Bhutan. Hauptthemen laut MEDLINE: Capsaicin, Osteoarthritis, Administration, Topical. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Thailand Science Research and Innovation.
Abstract (Originalsprache)
Osteoarthritis (OA) affects hundreds of millions of people worldwide. The objective was to critically appraise the efficacy and safety of topical capsaicin in reducing pain in OA. MEDLINE (PubMed) and Embase (Ebsco) were searched from inceptions until February 2023. The eligibility criteria included randomized controlled trials (RCTs), evaluating topical capsaicin in OA patients. Standard Cochrane methods were used to extract data and to appraise eligible studies. Eight double‐blind RCTs involving 498 patients were included. Five trials (62.5%) were at an overall low risk of bias, and three (37.5%) were at a high risk of bias. Meta‐analysis showed that, in various OA patients, compared with placebo, topical capsaicin (0.0125%–5%) may reduce pain severity measured with visual analog scale (standardized mean difference = −0.84, 95% confidence intervals [CIs] = −1.48 to −0.19, p = 0.01; eight studies). However, topical capsaicin may increase burning sensation at the application site (risk ratio = 5.56, 95% CI = 1.75–17.69, p = 0.004, numbers needed to harm = 3; five studies) when compared with placebo. Limitations include short study durations, small sample sizes, high heterogeneity, and overall low‐to‐very‐low certainty of the evidence. Topical capsaicin may reduce OA pain at follow‐ups of up to 3 months. Larger trials, potentially evaluating capsaicin in combination with phytopharmaceuticals having anti‐inflammatory effects, with longer follow‐ups might be needed to reduce the existing uncertainties. Topical capsaicin might be recommended for short‐term management of pain in OA patients intolerant to nonsteroidal anti‐inflammatory drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Royal Centre for Disease Control, Ministry of Health, Thimphu, Bhutan.
- Kleijnen Systematic Reviews Ltd., Escrick Business Park, York, UK.
- Faculty of Rehabilitation, University of Physical Education, Cracow, Poland.
- Centre for Safety and Quality in Health, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand.
- School of Pharmacy, University College London, London, UK.
ORCID-Profile: Chuenjid Kongkaew
Förderung
- Thailand Science Research and Innovation
Zitieren
APA
Tshering, G., Posadzki, P., & Kongkaew, C. (2024). Efficacy and safety of topical capsaicin in the treatment of osteoarthritis pain: A systematic review and meta‐analysis. Phytotherapy Research, 38(7), 3695-3705. https://doi.org/10.1002/ptr.8223
Vancouver
Tshering G, Posadzki P, Kongkaew C. Efficacy and safety of topical capsaicin in the treatment of osteoarthritis pain: A systematic review and meta‐analysis. Phytotherapy Research. 2024;38(7):3695-3705. doi:10.1002/ptr.8223
BibTeX
@article{Tshering2024,
author = {Tshering, Gyem and Posadzki, Pawel and Kongkaew, Chuenjid},
title = {Efficacy and safety of topical capsaicin in the treatment of osteoarthritis pain: A systematic review and meta‐analysis},
journal = {Phytotherapy Research},
year = {2024},
volume = {38},
number = {7},
pages = {3695--3705},
doi = {10.1002/ptr.8223}
}
EUVIMED